«Биткоиномания»: прогнозы и возможности
Профиль Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG is a holding company, which engages in the investment in companies that involve in innovative business concepts and technologies. It focuses on the indications sepsis and cancer, and primarily invests in research and development of drug candidates with unique selling proposition potential. The company was founded by Bernd Wegener and Andreas Bergmann on June 29, 2009 and is headquartered in Hennigsdorf, Germany.